Generation Bio Co expected to post a loss of 41 cents a share - Earnings Preview

Generation Bio

06/05/2024 12:25

* Generation Bio Co  GBIO.OQ   GBIO.O  is expected to show a
rise
in quarterly revenue when it reports  results on May 8
(estimated) for the period ending March 31 2024
    * The Cambridge Massachusetts-based  company is expected to
report
revenue of $1.92 million, according to the mean estimate from 5
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Generation Bio Co is for
a
loss of 41 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Generation
Bio Co
is $7.50​, above​ its last closing price of $3.17. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Dec. 31 2023  -0.44       -0.45      -0.53     Missed  -18.2
 Sep. 30 2023  -0.50       -0.50      -0.43     Beat    14.9
 Jun. 30 2023  -0.50       -0.50      -0.47     Beat    5.4​
 Mar. 31 2023  -0.45       -0.46      -0.53     Missed  -14.2
 ​​Dec.        -0.58       -0.58      -0.55     Beat    5
 31 2022                                                
 Sep. 30 2022  -0.66       -0.67      -0.53     Beat    21.1​
 Jun. 30 2022  -0.63       -0.62      -0.66     Missed  -6
 Mar. 31 2022  -0.53       -0.52      -0.61     Missed  -16.2
 This summary was machine generated May 6 at 11:25 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)